LURASIDONE GH, LURASIDONE LAPL, LURASIDONE LUPIN (Lupin Australia Pty Limited)
Product name
LURASIDONE GH, LURASIDONE LAPL, LURASIDONE LUPIN
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
135 working days (255)
Active ingredients
lurasidone hydrochloride
Registration type
New generic medicine
Indication
LURASIDONE GH, LURASIDONE LAPL, LURASIDONE LUPIN (film coated tablets) are indicated for the treatment of schizophrenia in adults and adolescents (aged 13 to 17 years).